Neurology

General Rheumatology

Questions discussed in this category

How do you manage a patient with giant cell arteritis treated with weekly tocilizumab and low dose glucocorticoid who develops sudden vision loss?

2 Answers available

When tapering moderate to high doses of long term steroids do you routinely monitor for adrenal insufficiency?

Do you attempt to taper fully or maintain at a low dose?

2 Answers available

How do you treat post-IVIG headache that is not responsive to Tylenol or NSAIDs?

Specifically, how do you treat the delayed headache, not the headache that develops during the infusion where pre-hydration and slowing down the rate ...

4 Answers available

When would you consider checking JC virus prior to initiating biologic therapy?

1 Answer available

Would you consider using a TNFi in a patient with a family history of demyelinating disease, in the absence of a personal history?

2 Answers available

How do you approach the use of biologics in patients with a history of Guillain-Barre syndrome?

1 Answer available

Papers discussed in this category

Arthritis and rheumatism, 2001-12

Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides.

Journal of neurovirology, 2018-06

Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event.

Arthritis Res Ther, 2021 Mar 22

Vision loss in patients with giant cell arteritis treated with tocilizumab.

Neurology

General Rheumatology

Questions discussed in this category

Papers discussed in this category

Related Topics in Neurology